Particle-Size Requirements Related to Content Uniformity of Solid Dosage Forms

1974 ◽  
Vol 63 (12) ◽  
pp. 1961-1963 ◽  
Author(s):  
M.C.R. Johnson
2003 ◽  
Vol 92 (7) ◽  
pp. 1526-1530 ◽  
Author(s):  
Tonglei Li ◽  
Amy D. Donner ◽  
Candice Y. Choi ◽  
Gerard P. Frunzi ◽  
Kenneth R. Morris

2021 ◽  
Vol 14 (5) ◽  
pp. 418
Author(s):  
Andrea Gabriela Crișan ◽  
Alina Porfire ◽  
Rita Ambrus ◽  
Gábor Katona ◽  
Lucia Maria Rus ◽  
...  

Three-dimensional printing (3DP) by fused deposition modeling (FDM) has gained momentum as a promising pharmaceutical manufacturing method due to encouraging forward-looking perspectives in personalized medicine preparation. The current challenges the technology has for applicability in the fabrication of solid dosage forms include the limited range of suitable pharmaceutical grade thermoplastic materials. Hence, it is important to investigate the implications of variable properties of the polymeric carrier on the preparation steps and the final output, as versatile products could be obtained by using the same material. In this study, we highlighted the influence of polyvinyl alcohol (PVA) particle size on the residence time of the mixtures in the extruder during the drug-loaded filament preparation step and the consequent impact on drug release from the 3D printed dosage form. We enhanced filament printability by exploiting the plasticizing potential of the active pharmaceutical ingredient (API) and we explored a channeled tablet model as a design strategy for dissolution facilitating purposes. Our findings disclosed a new perspective regarding material considerations for the preparation of PVA-based solid dosage forms by coupling hot melt extrusion (HME) and FDM-3DP.


2010 ◽  
Vol 11 (3) ◽  
pp. 1320-1327 ◽  
Author(s):  
Natalja Genina ◽  
Heikki Räikkönen ◽  
Osmo Antikainen ◽  
Jyrki Heinämäki ◽  
Jouko Yliruusi

Sign in / Sign up

Export Citation Format

Share Document